文献速递肺外科

疫苗接种后时代SARS-CoV-2感染后肺切除手术的安全性

Safety of lung resection surgery after severe acute respiratory syndrome coronavirus 2 infection in the post-vaccination era.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

这项回顾性单中心队列研究纳入2021年6月至2022年6月间接受肺切除的1194例患者,其中79例有SARS-CoV-2感染史(COVID-19组),66例(90.4%)至少接种过1剂疫苗。COVID-19组与非COVID-19组在主要并发症率(6.3% vs 5.4%,P=0.613)、呼吸并发症率(19.0% vs 12.2%,P=0.079)和住院时间(4.9±3.4 vs 5.0±5.6,P=0.992)上无显著差异。多因素logistic回归显示年龄、男性、肺功能检查差、开放手术和广泛肺切除是术后并发症的危险因素,而术前COVID-19感染状态不是统计学显著的危险因素。结论认为在疫苗接种后时代,SARS-CoV-2感染后短期内即可安全进行肺切除手术,甚至可在感染后4周内进行。

要点

  • COVID-19组与非COVID-19组主要并发症率(6.3% vs 5.4%,P=0.613)无显著差异。
  • 两组呼吸并发症率(19.0% vs 12.2%,P=0.079)和住院时间(4.9±3.4 vs 5.0±5.6,P=0.992)无显著差异。
  • 术前COVID-19感染状态不是术后并发症的统计学显著危险因素。

核心结论

  • 在疫苗接种后时代,SARS-CoV-2感染后短期内即可安全进行肺切除手术,甚至可在感染后4周内进行。

研究设计与样本

  • 回顾性单中心队列研究,纳入2021年6月至2022年6月间接受肺切除的患者1194例,其中79例有SARS-CoV-2感染史(COVID-19组),66例(90.4%)至少接种过1剂疫苗。

主要发现

  • COVID-19组与非COVID-19组主要并发症率分别为6.3%与5.4%(P=0.613),无显著差异。
  • COVID-19组与非COVID-19组呼吸并发症率分别为19.0%与12.2%(P=0.079),无显著差异。
  • COVID-19组与非COVID-19组住院时间分别为4.9±3.4与5.0±5.6(P=0.992),无显著差异。
  • 感染与手术的平均间隔为67天,对术后结局无显著影响。
  • 多因素logistic回归分析显示年龄、男性、肺功能检查差、开放手术和广泛肺切除是术后并发症的危险因素,而术前COVID-19感染状态不是统计学显著的危险因素。

临床怎么用

  • 原文结论认为在疫苗接种后时代,肺切除手术可在SARS-CoV-2感染后短期内安全进行,甚至可在感染后4周内进行。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the postoperative outcomes of lung resection in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and determine the optimal timing of surgery. METHODS: This retrospective, single-centre cohort study included patients who underwent lung resection between June 2021 and June 2022. Patients were divided into the coronavirus disease 2019 (COVID-19) and non-COVID-19 groups based on their preoperative SARS-CoV-2 infection history, and postoperative outcomes were compared. Logistic regression analysis was conducted to identify the risk factors of complications after lung resection surgery. RESULTS: In total, 1194 patients were enrolled, of whom, 79 had a history of SARS-CoV-2 infection. In the COVID-19 group, 66 patients (90.4%) had received at least 1 vaccination dose. The average interval between infection and surgery was 67 days, with no significant impact on postoperative outcomes. Regarding postoperative outcomes, there were no significant differences in major complication rate (6.3% vs 5.4%, P = 0.613), respiratory complication rate (19.0% vs 12.2%, P = 0.079) or length of stays (4.9 ± 3.4 vs 5.0 ± 5.6, P = 0.992) between the 2 groups. Multivariate logistic regression analysis revealed that age, male sex, poor pulmonary function test, open surgery and extensive lung resection were risk factors for postoperative complications, while preoperative COVID-19 infection status was not a statistically significant risk factor. CONCLUSIONS: In the post-vaccination era, lung resection surgery can be safely performed shortly after SARS-CoV-2 infection, even within 4 weeks of infection.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Im S, Na KJ, Park JH, et al. Safety of lung resection surgery after severe acute respiratory syndrome coronavirus 2 infection in the post-vaccination era. Eur J Cardiothorac Surg. 2024. PMID: 38532301. doi:10.1093/ejcts/ezae120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。